DrugDashboards

Heparin Sodium

Heparin Sodium · HEPARIN SODIUM 5000 [USP'U]/.5mL · Injection, Solution · Intravenous; Subcutaneous · Fresenius Kabi USA, LLC

NDC 63323-0118-05 · 24 BLISTER PACK in 1 CARTON / 1 SYRINGE in 1 BLISTER PACK / .5 mL in 1 SYRINGE · NDA · View full market →

The short version

15 companies supply this market — deep enough that no single failure threatens the supply. The brand price has held steady around $5.90 per mL over the past year. It is in shortage right now — FDA lists the reason as “other”. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$5.90per MLinvoice-surveyed acquisition cost · May 20, 2026
  • Medicare Part B pays (ASP+6%)$0.1990per billing unit (1000 UNITS)HCPCS J1644 · Jul 1, 2026
  • Part D plans paid (avg)$2.01per dosage unitgross, before rebates — matched by drug name · 2024
  • Federal contracts pay (FSS)$73.28per package of 24X0.5MLFresenius Kabi, LLC · May 15, 2025
  • Medicaid generic ceiling (FUL)$8.75per MLweighted avg manufacturer price $4.9982 · Jul 1, 2025148% of what pharmacies pay — higher than 81% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$2.50$5.00$7.50Nov 2024Sep 2026$5.90
12 price points · per ML · held since Invalid DateSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$74.40
Reported to Texas DSHS · 2026 annual filing · Fresenius Kabi USA

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 1000 UNITS
$0.199
HCPCS J1644 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$98
42 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

25● Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • related presentation in shortage+15
  • sterile injectable+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.6%chance of a new FDA shortage posting for heparin sodium (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 4× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $54.61 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA017029
TE code
AP
Approval date
Jan 1, 1982
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0431-03)Nov 14, 2017
    month 106 — 5× the typical 20-month injectable shortage · model puts 30% odds it resolves within 6 months
  • In shortage now — Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0433-04)Nov 14, 2017
    month 106 — 5× the typical 20-month injectable shortage · model puts 30% odds it resolves within 6 months
  • In shortage now — Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-10)Nov 14, 2017
    month 106 — 5× the typical 20-month injectable shortage · model puts 30% odds it resolves within 6 months
  • In shortage now — Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-77)Nov 14, 2017
    Other
    month 106 — 5× the typical 20-month injectable shortage · model puts 30% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Heparin Sodium (Injection, Solution)

LabelerStrengthFirst seenLast seen
Baxter Healthcare CorporationHEPARIN SODIUM 200 [USP'U]/100mLJul 15, 2026Sep 3, 2026
Cardinal Health 107, LLCHEPARIN SODIUM 5000 [USP'U]/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCHEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCHEPARIN SODIUM 5000 [USP'U]/100mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCHEPARIN SODIUM 5000 [USP'U]/.5mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCHEPARIN SODIUM 10000 [USP'U]/100mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCHEPARIN SODIUM 5000 [USP'U]/mLJul 15, 2026Sep 3, 2026
Hepalink USA Inc.HEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 3, 2026
Hepalink USA Inc.HEPARIN SODIUM 5000 [USP'U]/mLJul 15, 2026Sep 3, 2026
HF Acquisition Co LLC, DBA HealthFirstHEPARIN SODIUM 10000 [USP'U]/mLJul 15, 2026Sep 3, 2026
Hospira, Inc.HEPARIN SODIUM 200 [USP'U]/100mLJul 15, 2026Sep 3, 2026
Hospira, Inc.HEPARIN SODIUM 5000 [USP'U]/100mLJul 15, 2026Sep 3, 2026
Medical Purchasing Solutions, LLCHEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 3, 2026
Sandoz Inc.HEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 3, 2026
Sandoz Inc.HEPARIN SODIUM 10000 [USP'U]/mLJul 15, 2026Sep 3, 2026
BE Pharmaceuticals Inc.HEPARIN SODIUM 2000 [USP'U]/2mLJul 15, 2026Sep 2, 2026
BE Pharmaceuticals Inc.HEPARIN SODIUM 5000 [USP'U]/.5mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCHEPARIN SODIUM 5000 [USP'U]/.5mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCHEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCHEPARIN SODIUM 10000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCHEPARIN SODIUM 20000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCHEPARIN SODIUM 10000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCHEPARIN SODIUM 200 [USP'U]/100mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.HEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.HEPARIN SODIUM 5000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Hepalink USA Inc.HEPARIN SODIUM 10000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Hepalink USA Inc.HEPARIN SODIUM 20000 [USP'U]/mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstHEPARIN SODIUM 5000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Hospira, Inc.HEPARIN SODIUM 5000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Hospira, Inc.HEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Meitheal Pharmaceuticals Inc.HEPARIN SODIUM 5000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Meitheal Pharmaceuticals Inc.HEPARIN SODIUM 5000 [USP'U]/.5mLJul 15, 2026Sep 2, 2026
Northstar Rx LLCHEPARIN SODIUM 10000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Northstar Rx LLCHEPARIN SODIUM 5000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Northstar Rx LLCHEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Phlow CorporationHEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceticalsHEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceticalsHEPARIN SODIUM 10000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceticalsHEPARIN SODIUM 5000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsHEPARIN SODIUM 10000 [USP'U]/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Heparin Sodium — NDC 63323-0118-05," retrieved September 3, 2026, https://drugdashboards.com/drug/63323011805.

Free to cite with attribution — see how the data is put together.